Featured Dataverses

In order to use this feature you must have at least one published dataverse.

Publish Dataverse

Are you sure you want to publish your dataverse? Once you do so it must remain published.

Publish Dataverse

This dataverse cannot be published because the dataverse it is in has not been published.

Delete Dataverse

Are you sure you want to delete your dataverse? You cannot undelete this dataverse.

Advanced Search

1 to 10 of 137 Results
Replication Data for "In vitro effects of a novel somatostatin receptor 5-preferring agonist on human GH- and ACTH-secreting pituitary adenomas"
Dec 30, 2023 - Francesca Pecori Giraldi
Pecori Giraldi, Francesca, 2023, "Replication Data for "In vitro effects of a novel somatostatin receptor 5-preferring agonist on human GH- and ACTH-secreting pituitary adenomas"", https://doi.org/10.13130/RD_UNIMI/DXUJXX, UNIMI Dataverse, V1
IN VITRO EFFECT OF A NOVEL SOMATOSTATIN RECEPTOR 5-PREFERRING AGONIST ON HUMAN GH- AND ACTH-SECRETING PITUITARY ADENOMAS Details of ACTH and GH secretion and gene expression
PecoriGiraldi 2023 HTL.xls
Dec 30, 2023 - Replication Data for "In vitro effects of a novel somatostatin receptor 5-preferring agonist on human GH- and ACTH-secreting pituitary adenomas"
MS Excel Spreadsheet - 31.0 KB - MD5: f0557cafa1d8cb09998572b9b62be58f
Data
raw data for ACTH and GH measurements , SSTR2, SSTR3, SSTR5, POMC and GH expression n individual adenomas
Replication Data for "A β-Arrestin 2-Biased Dopamine Receptor Type 2 (DRD2) Agonist Is More Efficacious Than Cabergoline in Reducing Cell Proliferation in PRL-Secreting but Not in Non-Functioning Pituitary Tumor Cells"
Oct 5, 2023 - Replication data for papers
Peverelli, Erika, 2023, "Replication Data for "A β-Arrestin 2-Biased Dopamine Receptor Type 2 (DRD2) Agonist Is More Efficacious Than Cabergoline in Reducing Cell Proliferation in PRL-Secreting but Not in Non-Functioning Pituitary Tumor Cells"", https://doi.org/10.13130/RD_UNIMI/EUJIOW, UNIMI Dataverse, V1
This dataset has been created to share experimental data of the present paper, so that files supporting published data have been made available.
Fig.1b - Cyclin D3.JPG
Oct 5, 2023 - Replication Data for "A β-Arrestin 2-Biased Dopamine Receptor Type 2 (DRD2) Agonist Is More Efficacious Than Cabergoline in Reducing Cell Proliferation in PRL-Secreting but Not in Non-Functioning Pituitary Tumor Cells"
JPEG Image - 57.1 KB - MD5: 57a603c7dc1729bb8d2c68de61e182bc
Western blot original image of cyclin D3 detection.
Fig. 1b - GAPDH.JPG
Oct 5, 2023 - Replication Data for "A β-Arrestin 2-Biased Dopamine Receptor Type 2 (DRD2) Agonist Is More Efficacious Than Cabergoline in Reducing Cell Proliferation in PRL-Secreting but Not in Non-Functioning Pituitary Tumor Cells"
JPEG Image - 140.1 KB - MD5: 8e1e467a59879b3d88aec6ca4072cf1e
Western blot original image of GAPDH detection.
Fig. 1e - AKT.JPG
Oct 5, 2023 - Replication Data for "A β-Arrestin 2-Biased Dopamine Receptor Type 2 (DRD2) Agonist Is More Efficacious Than Cabergoline in Reducing Cell Proliferation in PRL-Secreting but Not in Non-Functioning Pituitary Tumor Cells"
JPEG Image - 92.7 KB - MD5: 87331fdd104e2841b25e049c627372a6
Western blot original image of AKT detection.
Fig. 1e - pAKT.JPG
Oct 5, 2023 - Replication Data for "A β-Arrestin 2-Biased Dopamine Receptor Type 2 (DRD2) Agonist Is More Efficacious Than Cabergoline in Reducing Cell Proliferation in PRL-Secreting but Not in Non-Functioning Pituitary Tumor Cells"
JPEG Image - 56.1 KB - MD5: 39c3000b8f45a1208d3ff0d02a687071
Western blot original image of phosphorylated AKT detection.
Fig. 1g - AKT.JPG
Oct 5, 2023 - Replication Data for "A β-Arrestin 2-Biased Dopamine Receptor Type 2 (DRD2) Agonist Is More Efficacious Than Cabergoline in Reducing Cell Proliferation in PRL-Secreting but Not in Non-Functioning Pituitary Tumor Cells"
JPEG Image - 71.8 KB - MD5: 1f2ca883c89cc38113556014b42e85d4
Western blot original image of AKT detection.
Fig. 1g - pAKT.JPG
Oct 5, 2023 - Replication Data for "A β-Arrestin 2-Biased Dopamine Receptor Type 2 (DRD2) Agonist Is More Efficacious Than Cabergoline in Reducing Cell Proliferation in PRL-Secreting but Not in Non-Functioning Pituitary Tumor Cells"
JPEG Image - 995.4 KB - MD5: 12a56b36aa19b69ced057f66048f5d43
Western blot original image of phosphorylated AKT detection.
README.md
Oct 5, 2023 - Replication Data for "A β-Arrestin 2-Biased Dopamine Receptor Type 2 (DRD2) Agonist Is More Efficacious Than Cabergoline in Reducing Cell Proliferation in PRL-Secreting but Not in Non-Functioning Pituitary Tumor Cells"
Markdown Text - 696 B - MD5: a19852481207f570c6ca476e3c869f87
Uploaded files description
Add Data

Sign up or log in to create a dataverse or add a dataset.

Sign Up Log In
Share Dataverse

Share this dataverse on your favorite social media networks.

Link Dataverse
Reset Modifications

Are you sure you want to reset the selected metadata fields? If you do this, any customizations (hidden, required, optional) you have done will no longer appear.